No Data
No Data
Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$6.29 From HK$8.45, Keeps at Buy
Shandong Weigao Group Medical Polymer Company Limited Goes Ex Dividend Tomorrow
SHANDONG WEIGAO GP To Go Ex-Dividend On July 22nd, 2024 With 0.05297 USD Dividend Per Share
China's Medical Device Market Value Hits $179B, 90th CMEF in Shenzhen to Feature a Plethora of Technological Products
Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Have Declined Over Three Years, Contributing to Shareholders 73% Loss
Sinolink Securities: The pharmaceutical sector is expected to see an improvement in market conditions in the third quarter, and overall growth expectations for the second half of the year are optimistic.
Sinolink Securities released a research report stating that considering the improvement in the medical insurance settlement cycle, the expectation of policy improvement, and the recovery performance of the industry, as well as the fact that institutional medicine hold positions are at a low level, the medical sector will usher in an improved market situation in Q3.
No Data